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In advanced heart failure, mitral regurgitation i creases 
the burden of the failing ventricle and decreases ffective 
stroke volume. Although tailored afterload reduction de- 
creases mitral regurgitation at rest, it is not known if this 
benefit smaintained during upright exercise. Simultaneous 
radionuclide ventriculography and thermodilution stroke 
volumes were compared to measure the forward ejection 
fraction in 10 patients during upright bicycle exercise 
before and after therapy with vasodilators and diuretics 
tailored to decrease pulmonary capillary wedge pressure 
and systemic vase&r resistance. 
Ventricular volumes, total ejection fraction and the 
forward ejection fraction did not change during exercise at
baseline. At rest, tailored therapy decreased average pul- 
monary capillary wedge pressure from 26 to 19 mm Hg 
(p < O.Ol), systemic vascular resistance from 1,570 to 1,210 
In patients with advanced heart failure, mitral regurgitation 
increases the burden of the failing ventricle (1) and decreases 
effective stroke volume. Therapy taiiored specifically to 
decrease pulmonary capillary wedge pressure as well as 
systemic vascular resistance improves clinical status in such 
patients (2,3) while decreasing ventricular volumes and 
mitral regurgitation, which is the main mechanism bywhich 
forward stroke volume is increased (4,5). However, upright 
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dynes-scmW5 (p C ME), and left ve~tri~~iar volu 
from 251 to 177 ml/m2 (p C 0.01), while increasing the 
forward ejection fraction from 0.53 to 0.85 (p C 0.01) 
without change in total ejection fraction (0.18 from 0.1 
During steady state exercise at low work load, tailo 
therapy decreased left ventri ume index from 279 
213 (p c 0.05) and increased ejection 
0.52 to 0.79 (p C 0.01) wi ange in 
fraction (0.20 from 0.19). 
The total stroke volume during exercise 
creased after therapy; the increase in forwar 
ume after therapy appeared to result instead from the 
decrease in mitral regurgitant low e benefits of tailored 
afterload reduction are maintain throughout upright 
exercise. 
(J Am Co11 Cardiol~99~;lS:~7~-~0~ 
exercise may alter ventricular volumes and mitral regurgita- 
tion as venous return and systemic vascular esistance 
change. Tailored therapy that reduces ventricular volume 
and mitral regurgitation in the supine patient with advanced 
heart failure has not been similarly assessed uring upright 
exercise, although this may be more important during sus- 
tained therapy for ambulatory patients. 
The purpose of this study ofpatients with advanced heaFt 
failure was to test the hypotheses that 1) afterload reduction 
that decreases mitral regurgitation atrest decreases mitral 
regurgitation during upright exercise, and 2) the increase in 
exercise stroke volume occurring after tailored therapy 
results from a decrease inmitral regurgitation rather than an 
increase in total stroke volume. 
Study patients. In IO consecutive patients with ejection 
fraction CO.25 and pulmonary capillary wedge pressure >25 
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to 6 h. The design for oral afterload r 
the same be~~odynami~ goals rather 
or to relative bemodynamic changes. 
ients were restudi h after systemic 
va ar resistance of 51 -’ and pulmonary 
capillary wedge pressure been documented 
at least once and repeat radionuclide study could be per- 
formed. The hemodynamic measiiremefits i;sed for ca!cl;!a- 
tion were those obtained simultaneously with radionuclide 
data and were not always the optimal hemodynamic values 
achieved. At the time of restudy, six patients were still 
receiving ~itro~~~ss~de an  four patients were taking or 
eas s. mody~amic k3lues 
were measured with a 7F therm ution balloon-tipped 
catheter inserted ~erc~taneo~s~y into the jugular vein and 
advanced to the pulmonary artery, where placement in 
pulmonary artery wedge position was initially confirmed by 
fluoroscopy. Pulmonary capillary wedge pressure was deter- 
volume of the blood snmple was ~alc~lQted by 
interval. Sample counts were also corrected for isotope 
decay and length of acquisition time, in order t 
counts per milliliter of the blood sample to obser 
ular counts. The attenuation factors were determined sepa- 
rate!y for supine and Gttirg positims. 
Ventricular volumes were calculated by dividing attenu- 
ation-adjusted ventrkular calms by sample counts per 
riilliliter: 
Volume (ml) = 
corrected ventricular countslatl trnuatiorl Factor 
corrected sample counts/sample volume (ml) * 
ionuclide stroke volume was the d 
diastolic and end-systolic volu es. Tbe forward 4ec- 
lion fraction was deemed a4 the ratio of tbermodi~~tio~ 
stroke volume to radionuclide stroke volume (total stroke 
volume) (4). 
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Figure 1. Pulmonary capillary wedge 
pressure and systemic vascular resis- 
tance in 10 patients with advanced 
heart failure during supine rest, up- 
right (Up) rest, bicycle xercise (Ex.) 
work load in only 4 patients before 
therapy and in all 10 patients after 
I I 1 I 
Su~ina Up El. MorElI. Reeouary supine UP Ea. MOLEI. f?~cou(ny cate significant change occurring dur- 
Exercise testing, Exercise testing was performed in the 
upright sitting position with use of an attached cycle ergom- 
eter with settings of no load, and 2540 and 70 W. Exercise 
was begun at 25 W except in three patients who could 
perform only unloaded cycling (on this bicycle, approxi- 
mately 15 W). After 2 min of the initial work load, imaging 
was performed for 180 s during which hemodynamic mea- 
surements were also made. Acquisition at higher work loads 
was begun after 1 min and continued for 180 s, during which 
hemodynamic measurements were again performed. The 
exercise protocol was duplicated for the repeat study after 
therapy, with the initial exercise imaging performed at the 
same time and work lead as before therapy. Those patients 
able to sustain higher work loads underwent imaging also at 
the maximal level attained, and such data were included as 
maximal exercise. One patient’s upine values were ex- 
cluded because of an error in placement ofthe pain? source. 
Because one patient’s post-therapy exercise at 25 W was 
inadequately imaged, his pre- and post-therapy exercise 
images at 40 W were used for the initial work load. Recovery 
data were obtained inthe upright position after 1 min of rest 
for all except one patient, in whom count recovery was 
inadequate. 
Echecardiography. Echocardiography was performed as 
part of the initial evaluation prior to admission. A Hewlett- 
Packard 7702OAC phased-array, two-dimensional echocar- 
diograph with pulsed and continuous wave Doppler ecord- 
ing capability was used. The mitral valve apparatus was 
studied specifically for evidence of primary abnormality, 
which was not found in any patient. Mitral regurgitation was 
defined as the presence ofpansystolic flow directed into the 
atrium behind the mitral eatlets on pulsed and continuous 
wave Doppler ecording. Semiquantitative assessment of
regurgitation severity was made on a 1 to 3 scale according 
to the extent of flow disturbance within the left atrium. 
StMstics. The effects of exercise were assessed using 
one-way analysis of variance for repeated measures, with F 
statistics evduated by Wilks’ lambda method. To identify 
ing exercise. 
the significant differences, exercise values were campared. 
with upright rest values with the use of paired t tests. 
Differences resulting from therapy were compared at eat 
time by paired r tests. Two-way analysis of variance was 
used to determine if the pattern of response to exercise was 
different after therapy. All mean values are expressed with 
standard eviations, and p < 0.05 was considered signifi- 
cant. 
Initial evaluation. The 10 patients had beeu referred wi 
eart Association class III or IV sym 
on <0.25 (0.17 f 0.04), and pulmonary 
capillary wedge pressure >25 mm Hg (36 2 5) a! the time of 
evaluation for cardiac transplantation. Echocardiography, 
which had been performed before the initial study, showed 
left ventrtcular end-diastolic dimension of 72 2 8 mm, left 
atria1 dimension of 51 t 6 mm and mitral regurgitation in all 
patients, with severity 2.3 2 0.7 on 3 0 to 3 scale. The initial 
forward ejection fraction, calculated as the ratio of thermodi- 
lution stroke volume to radionuclide stroke volume (total 
stroke volume), was 0.53 f 0.43. 
Initial exercise. During exercise before revision of ther- 
apy, pulmonary capillary wedge pressure increased to 41 + 
5 mm Hg and systemic vascular esistance decreased to 
1,180 + 320 dynes-s-cm- 5 (Fig. 1). These changes during 
exercise were not significant by analysis of variance. Left 
ventricular end-diastolic volume and total ejection fraction 
did not change from upright rest to end-exercise (269 to 279 
ml/m* and 0.18 to 0.19, respectively). Total stroke volume 
and forward stroke volume were also unchanged (Fig. 2), 
although a small increase in cardiac output resulted from an 
increase in heart rate (98 to 115 beatsjmin, p < 0.05). The 
forward ejection fraction atso was unchanged during exer- 
cise and recovery (Fig. 3). 
red therapy at rest (Table 1). After 24 to 72 
h of vasodilator and diuretic therapy, pulmonary capillary 
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Total stroke vo9ume (from 
viations and symbols as in Figure I. 
rate did not change. 
volume index decreas 
no6 mcrease and 
gure 3. The forward ejection fraction in 10 patient3 with heart 
iiure. Values hown are those obtained before (4i e) and after 
) tailored therapy (measurements made as in Fig. 9). 
Asterisks reflect significant change after therapy; changes occurring 
during exercise were not sign&ant. Abbreviations as in Figure 9. 
I 
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Supine Up Ex. Mox.Ex. Racowy 
s PC005 
ot to the baseline l vel before 
the increase in the forw 
the redist~but~o~ of mit w that increased 
eke volume at supine rest was maiac 
rcise. The forward ejection fr
cise. 
After therap.v, aii IO patients wert? able to exercise 
nd the initial 5 min period. ise time increased 
4to9~~4mio~~<~ maxima9 work load 
from 28 t 99 to 43 J 
exercise, fu 
wedge pres rate were ac 
.uther modest fal9 in systemic vascular resistance witbont 
detectable change io left ventricnlar en -diastolic vo9ume, 
ejection fraction or forward ejection fraction. 
The four patients whose left ve~t~c~lar f ilure was at- 
tributed to severe coronary artery disease demonstrated 
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Table 1. Supine Measurements Before and After Therapy Tailored to Hemodynamic Goals in 10 
Patients With Advanced Heart Failure 
After 
Initial Tailored Therap! : 
.:- 
p Value % Change 
Pulmonary capillary wedge 36 f 5 19 + 3 :n %I 48 + 9 
pressure (mm Hg) 
Systemic vascular resistance 1.570 4 450 1,210 + 320 co.05 19 f 24 
(dynevscm-‘1 
Cardiac index (IitersImin per mZ) 1.9 f 0.6 2.6 2 0.6 CO.005 49 + 41 
Stroke volume (ml) 38 + 17 53 f 16 c0.001 53 f 44 
Heart ate (beMmin) 982 12 972 13 
Right atrial pressure (mm Hg) 20 I 6 723 <O.ciIl 65 + 14 
Left ventricular end-diastolic 251 + 154 177 + 103 <O.Oi 26 r 20 
volume index (mVm*) 
Ejcclion fraction 0.17 f 0.04 0.18 1: 0.06 
Forward ejection fraction 0.53 f 0.44 0.85 .c 0.38 CO.01 110 f 83 
Serum sodium (mEq/liter) 135 + 5 134 f 3 
Serum creatinine (mgldl) 1.2 -+ 0.3 1.3 2 0.4 
patterns similar to those described for the group with nonis- 
chemic ardiomyopathy except for one patient with coro- 
nary artery disease and occluded bypass grafts whose pul- 
monary capillary wedge pressure after therapy rose from 8 to 
30 mm Hg during the first 3 min of exercise. 
ssio 
This study of patients with advanced heart failure dem- 
onstrated that afterload reduction with vasodilators and 
diuretics, which decreased left ventricular volume and mitral 
regurgitation in the supine position, also effectively reduced 
ventricular volume and mitral regurgitation during upright 
exercise. Furthermore, the increase in forward stroke vol- 
ume with therapy did not result from any increase in total 
stroke volume, but from the redistribution f mitral regur- 
gitant flow, which is as important for cardiac output during 
upright exercise as during supine rest. 
Goals of true afterload reduction. Traditionally, afterload 
reduction has been equated with vasodilator reduction of 
systemic vascular resistance, but the failing ventricle must 
also overcome the internal load related to ventricular pres- 
sure and vclume (8) that is further increased by mitral 
regurgitation. Although reduction of tilli~~g pressures, vol- 
ume and regurgitation has been classified as “preload reduc- 
tion,” such therapy is actually a major component of true 
afterload reduction. 
Therapy tailored to approach goals of pulmonary capil- 
lary wedge pressure 515 mm Hg and systemic vascular 
resistance ~1,200 dynes.s.cm- 5 has previously been shown 
(2M) to redu. ventricular volumes and mitral regurgita- 
tion while maximizing stroke volume at rest during acute 
therapy, following which the hemodynamic goals can then 
be subsequently matched by high doses of oral vasodilators 
and diuretics that have allowed sustained clinical improve- 
neent (3). The general efficacy of vasodilator therapy for 
improving exercise hemodynamics has been shown previ- 
ously for patients with primary mitral nzgurgitation a d good 
left ventricular function (9,10), as well as for patients with 
chronic left vrentricular f ilure in whom the role of mitral 
regurgitation was not determined (11,12). However, this 
study demonstrates the importance of mitral regurgitation 
during exercise before and after tailored therapy ir! patients 
with chronic ilear! faihnz. 
ynaaPlic miMII regur tioa. itra! regurgitation is
present in almost all patients with severe heart failure (I), 
resulting in part from ventricular dilation (1,13), and also in 
patients with coronary disease from dysfunction of the 
supporting structures ofthe valve (14). The relative cottri- 
butions of ventricular dilation and arterial impedance are 
difficult o separate. When systemic vascular resistance is
the target of therapy, there is some associated reduction in 
pulmonary capillary wedge pressure, although not to the 
extent achieved when reduction of fdling pressure and 
volume are specific goals. In a canine model (151, decreased 
ventricular volume appeared more important than pressure 
gradients for the reduction of mitral regurgitation. f  the 
current study in which the fraction ejected forward increased 
from 50% to 80%, pulmonary wedge pressure decreased by 
48%, with a 26% reduction in ventricular volume tiaat was 
maintained during exercise, while systemic vascular resis- 
tance decreased by 19% at rest during therapy and was not 
decreased significantly during exercise after therapy. 
The apparent greater importance of ventricular volumes 
may reflect our patient population, selected on the basis of 
initial filling pressure >25 mm Hg. The baseline systemic 
vascular resistance was already lower than that reported in 
many studies, reflecting the long-term use of vasodilators in 
all except one of our patients before the baseline study. 
Although all of these patients had also been receiving regular 
JACC Vol. 15, No. I 
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previously reported interobserver va~abil~ty for severely 
dilated ventricles to be 6.5% for vent~cu~ar counts and 2.6% 
for attenuation factors, yielding a total volume estimate 
variability of 8.5% (5). As the ejection fraction 
compares thermod~lotion stroke with radionuclide 
stroke volume, an additional source of error could arise from 
the thermodilution technique in patients with tricuspid re- 
gurgi~tioo. Bn a si 
plant evaluation (261, 
and Fick cardiac out 
the forward stroke volume change, the increases in the 
fomard ejection fraction after therapy are significant a the 
p .C 0.025 level. 
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